Skip to main content
NCBI home page
Gut logoLink to Gut
. 1988 Mar;29(3):385–389. doi: 10.1136/gut.29.3.385

Treatment of ulcerative reflux oesophagitis with colloidal bismuth subcitrate in combination with cimetidine.

M V Borkent 1, J A Beker 1
PMCID: PMC1433602  PMID: 3281872

Abstract

Twenty patients took part in a controlled double blind study comparing the efficacy of colloidal bismuth and cimetidine (800 mg at night) with cimetidine alone in the treatment of ulcerative reflux oesophagitis. Colloidal bismuth 120 mg was administered through an intraoesophageal tube four times a day. Cimetidine with colloidal bismuth gives significantly (p less than 0.001) better results than cimetidine alone. Of 10 patients treated with cimetidine and bismuth, seven had no endoscopic signs of oesophagitis after three weeks and three had grade I oesophagitis. Of 10 patients treated with cimetidine alone, one had grade I oesophagitis and three grade II oesophagitis after three weeks. The remaining six still had grade III oesophagitis. This study also shows that in nine of 10 patients reflux oesophagitis was accompanied by infection with campylobacter like organisms (CLO). After treatment the bacteria disappeared promptly in five patients receiving combination therapy and in two of four treated with cimetidine alone. The possible role of CLO in reflux oesophagitis is uncertain.

Full text

PDF
385

Images in this article

388Fig. 3
on p.388

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen L. P., Holck S., Povlsen C. O., Elsborg L., Justesen T. Campylobacter pyloridis in peptic ulcer disease. I. Gastric and duodenal infection caused by C. pyloridis: histopathologic and microbiologic findings. Scand J Gastroenterol. 1987 Mar;22(2):219–224. doi: 10.3109/00365528708991883. [DOI] [PubMed] [Google Scholar]
  2. Baldi F., Corinaldesi R., Ferrarini F., Stanghellini V., Miglioli M., Barbara L. Gastric secretion and emptying of liquids in reflex esophagitis. Dig Dis Sci. 1981 Oct;26(10):886–889. doi: 10.1007/BF01309491. [DOI] [PubMed] [Google Scholar]
  3. Behar J., Ramsby G. Gastric emptying and antral motility in reflux esophagitis. Effect of oral metoclopramide. Gastroenterology. 1978 Feb;74(2 Pt 1):253–256. [PubMed] [Google Scholar]
  4. Demeester T. R., Johnson L. F., Joseph G. J., Toscano M. S., Hall A. W., Skinner D. B. Patterns of gastroesophageal reflux in health and disease. Ann Surg. 1976 Oct;184(4):459–470. doi: 10.1097/00000658-197610000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dodds W. J., Dent J., Hogan W. J., Helm J. F., Hauser R., Patel G. K., Egide M. S. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med. 1982 Dec 16;307(25):1547–1552. doi: 10.1056/NEJM198212163072503. [DOI] [PubMed] [Google Scholar]
  6. Fricker C. R. Adherence of bacteria associated with active chronic gastritis to plastics used in the manufacture of fibreoptic endoscopes. Lancet. 1984 Apr 7;1(8380):800–800. doi: 10.1016/s0140-6736(84)91322-9. [DOI] [PubMed] [Google Scholar]
  7. Johnson L. F., Demeester T. R. Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol. 1974 Oct;62(4):325–332. [PubMed] [Google Scholar]
  8. Kaye M. D. Postprandial gastro-oesophageal reflux in healthy people. Gut. 1977 Sep;18(9):709–712. doi: 10.1136/gut.18.9.709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Little A. G., DeMeester T. R., Kirchner P. T., O'Sullivan G. C., Skinner D. B. Pathogenesis of esophagitis in patients with gastroesophageal reflux. Surgery. 1980 Jul;88(1):101–107. [PubMed] [Google Scholar]
  10. Marshall B. J. Campylobacter pyloridis and gastritis. J Infect Dis. 1986 Apr;153(4):650–657. doi: 10.1093/infdis/153.4.650. [DOI] [PubMed] [Google Scholar]
  11. Marshall B. J., McGechie D. B., Rogers P. A., Glancy R. J. Pyloric Campylobacter infection and gastroduodenal disease. Med J Aust. 1985 Apr 15;142(8):439–444. doi: 10.5694/j.1326-5377.1985.tb113444.x. [DOI] [PubMed] [Google Scholar]
  12. McNulty C. A. The treatment of campylobacter infections in man. J Antimicrob Chemother. 1987 Mar;19(3):281–284. doi: 10.1093/jac/19.3.281. [DOI] [PubMed] [Google Scholar]
  13. Patrick W. J., Denham D., Forrest A. P. Mucous change in the human duodenum: a light and electron microscopic study and correlation with disease and gastric acid secretion. Gut. 1974 Oct;15(10):767–776. doi: 10.1136/gut.15.10.767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Taylor D. E., Hargreaves J. A., Ng L. K., Sherbaniuk R. W., Jewell L. D. Isolation and characterization of Campylobacter pyloridis from gastric biopsies. Am J Clin Pathol. 1987 Jan;87(1):49–54. doi: 10.1093/ajcp/87.1.49. [DOI] [PubMed] [Google Scholar]
  15. Tytgat G. N. De Campylobacter pyloridis-story. Ned Tijdschr Geneeskd. 1986 Mar 8;130(10):435–436. [PubMed] [Google Scholar]
  16. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983 Jun 4;1(8336):1273–1275. [PubMed] [Google Scholar]
  17. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983 Jun 4;1(8336):1273–1275. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES